Update on Comprehensive Test Ban, & More from CRS
The Congressional Research Service has prepared an updated account of the status of the comprehensive nuclear test ban treaty (CTBT), which would prohibit explosive testing of nuclear weapons.
“As of August 2016, 183 states had signed the CTBT and 164, including Russia, had ratified it. However, entry into force requires ratification by 44 states specified in the treaty, of which 41 had signed the treaty and 36 had ratified.” The U.S. has not ratified it.
The Senate Foreign Relations Committee will hold a hearing on the CTBT tomorrow, September 7.
See Comprehensive Nuclear-Test-Ban Treaty: Background and Current Developments, September 1, 2016.
Other new and updated products from the Congressional Research Service include the following.
Climate Change: Frequently Asked Questions about the 2015 Paris Agreement, September 1, 2016
U.S. Textile Manufacturing and the Proposed Trans-Pacific Partnership Agreement, September 1, 2016
Comparing DHS Component Funding, FY2017: Fact Sheet, September 2, 2016
OPM Announces Premium Increase in the Federal Long-Term Care Insurance Program, CRS Insight, September 1, 2016
The European Union’s Small Business Act: A Different Approach, September 1, 2016
Zika Response Funding: Request and Congressional Action, updated September 1, 2016
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.